Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;9(12):ofac649.
doi: 10.1093/ofid/ofac649. eCollection 2022 Dec.

The Rise in Prevalence and Related Costs of Nontuberculous Mycobacterial Diseases in South Korea, 2010-2021

Joong-Yub Kim  1 , Nakwon Kwak  1 , Jae-Joon Yim  1
Affiliations

The Rise in Prevalence and Related Costs of Nontuberculous Mycobacterial Diseases in South Korea, 2010-2021

Joong-Yub Kim et al. Open Forum Infect Dis. .

Abstract

Between 2010 and 2021, the annual prevalence of nontuberculous mycobacterial (NTM) diseases in South Korea increased from 11.4 to 56.7 cases per 100 000 population. Prevalence in the population aged ≥65 years quadrupled from 41.9 to 163.1 cases per 100 000 population. Accordingly, the overall cost associated with NTM diseases increased.

Keywords: Mycobacterium abscessus; Mycobacterium avium; epidemiology; expenditure; prevalence.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. All authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
The epidemiology and direct medical expenditure associated with NTM diseases in South Korea between 2010 and 2021. (A) Prevalence of TB and NTM by year. (B) Prevalence of NTM by age groups (2010–2021). (C) Proportion (%) of patients ≥65 years. (D) Mean individual expenditure by age groups (2010–2021). Abbreviations: NTM, nontuberculous mycobacterial; TB, tuberculosis.
See this image and copyright information in PMC

References

    1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367–416. - PubMed
    1. Lee H, Myung W, Koh WJ, Moon SM, Jhun BW. Epidemiology of nontuberculous mycobacterial infection, South Korea, 2007–2016. Emerg Infect Dis 2019; 25:569–72. - PMC - PubMed
    1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U. S. Medicare beneficiaries. Am J Respir Crit Care Med 2012; 185:881–6. - PMC - PubMed
    1. Cowman S, van Ingen J, Griffith DE, Loebinger MR. Non-tuberculous mycobacterial pulmonary disease. Eur Respir J 2019; 54:1900250. - PubMed
    1. Kwon S. Thirty years of national health insurance in South Korea: lessons for achieving universal health care coverage. Health Policy Plan 2009; 24:63–71. - PubMed